Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archinte.1951.03810050045005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Relapsing sclerosing mesenteritis with multiple strictures of the small intestine.
Clin J Gastroenterol
October 2024
Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.
Article Synopsis
- * A patient with a history of small bowel surgery faced recurrent symptoms 10 years later and was hospitalized, where multiple intestinal strictures were discovered.
- * Following surgery and a diagnosis of SM, treatment with corticosteroids significantly improved the patient's symptoms, leading to a prolonged remission period.
Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT.
Medicine (Baltimore)
October 2023
Department of Hematology, People's Liberation Army the General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Rationale: Subcutaneous panniculitis like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma that belongs to peripheral T cell lymphomas, of which the overall prognosis is poor. Chidamide, a deacetylase inhibitor, has been approved for the treatment of peripheral T cell lymphomas. However, due to the rare occurrence of SPTCL, it is currently unknown whether Chidamide is effective for all SPTCL patients and whether there are molecular markers that can predict its therapeutic effect on SPTCL.
View Article and Find Full Text PDFInnate immune responses in Behçet disease and relapsing polychondritis.
Front Med (Lausanne)
June 2023
Department of Immunology and Parasitology, St. Marianna University of School of Medicine, Kawasaki, Kanagawa, Japan.
Behçet disease (BD) and relapsing polychondritis (RP) are chronic multisystem disorders characterized by recurrent flare-ups of tissue inflammation. Major clinical manifestations of BD are oral aphthae, genital aphthous ulcers, skin lesions, arthritis, and uveitis. Patients with BD may develop rare but serious neural, intestinal, and vascular complications, with high relapse rates.
View Article and Find Full Text PDF[Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review].
Beijing Da Xue Xue Bao Yi Xue Ban
December 2022
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Hemophagocytic syndrome (HPS) is a severe disease characterized by excessive release of inflammatory cytokines caused by abnormal activation of lymphocytes and macrophages, which can cause multiple organ damage and even death. Panniculitis is a disease characterized by inflammation of subcutaneous adipose tissue. We effectively treated 2 patients with panniculitis-associated HPS with ruxolitinib.
View Article and Find Full Text PDFRelapsing subcutaneous panniculitis-like T-cell lymphoma with B symptoms, remitting on low dose methotrexate.
J Dtsch Dermatol Ges
October 2022
Department of Pathology, PGIMER, Chandigarh, India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!